Non-alcoholic fatty liver disease fibrosis score is a useful tool for carotid atherosclerosis screening in patients with obstructive sleep apnea

doi:10.3748/wjg.117715

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 32, Issue 27

This Article

(17)

(12)

(0)

(191)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Gastroenterol. Jul 21, 2026; 32(27): 117715
Published online Jul 21, 2026. doi: 10.3748/wjg.117715

Full Size Figure Download Figure

Figure 1 Flowchart with the case selection of patients included in the study. 221 patients were enrolled because of snoring and/or obstructive sleep apnea suspicion. 74 patients were discarded due to chronic obstructive pulmonary disease and 3 due to missing relevant data. After performing night polysomnography, 112 patients were diagnosed as obstructive sleep apnea and 32 were enrolled as matched control subjects. OSA: Obstructive sleep apnea; COPD: Chronic obstructive pulmonary disease.

Citation: Fernández-García CE, Hernández-García MÁ, Aldave-Orzáiz B, Ávalos Pérez-Urría E, Muñoz JM, Friera A, García-Monzón C, Landete P, González-Rodríguez Á. Non-alcoholic fatty liver disease fibrosis score is a useful tool for carotid atherosclerosis screening in patients with obstructive sleep apnea. World J Gastroenterol 2026; 32(27): 117715
URL: https://www.wjgnet.com/1007-9327/full/v32/i27/117715.htm
DOI: https://dx.doi.org/10.3748/wjg.117715

Fernández-García CE, Hernández-García MÁ, Aldave-Orzáiz B, Ávalos Pérez-Urría E, Muñoz JM, Friera A, García-Monzón C, Landete P, González-Rodríguez Á. Non-alcoholic fatty liver disease fibrosis score is a useful tool for carotid atherosclerosis screening in patients with obstructive sleep apnea. World J Gastroenterol 2026; 32(27): 117715 [DOI: 10.3748/wjg.117715]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.